Search - tctmd.com

Displaying 1 - 20 of 107

Sort: Relevancy | Date

News Industry News

Pi-Cardia Reports First Commercial Cases with ShortCut™

March 03, 2025

News Industry News

Pi-Cardia Receives FDA Market Clearance for ShortCut™

October 01, 2024

News Industry News

NuVera Medical Announces Positive Results From First-in-human Feasibility Study At 2020 TCT Conference

October 14, 2020

News Industry News

Cardiac Dimensions Announces Australian Therapeutic Goods Administration's Approval of the Carillon System for the Treatment of Functional Mitral Regurgitation

September 02, 2020

News Industry News

New Data Confirms Cardiac Dimensions’ Carillon® System Shows Favorable Long-Term Survival Rate In Patients With Functional Mitral Regurgitation

February 25, 2020

News Industry News

Abbott Announces European Approval Of Two Life-Saving Heart Devices For Babies And Children

September 17, 2019

News Industry News

Reduce Fmr Study Shows Cardiac Dimensions’ Carillon® System Significantly Improves Mitral Regurgitation And Slows Worsening Of Heart Failure

September 12, 2019

News Industry News

Abbott Launches World's First Pivotal Trial To Test New Approach For Repairing Leaky Tricuspid Heart Valves

September 05, 2019

News Industry News

Neovasc Provides Further Update on Reducer™ Program for Treatment of Refractory Angina

July 16, 2019

News Industry News

Abbott Receives U.S. Approval Of Next-Generation Mitraclip™, Bringing New Enhancements To Abbott's Leading Mitraclip Platform

July 15, 2019

News Industry News

Cardiac Dimensions Reaches 1,000 Implants Of Carillon® System, A Minimally Invasive Treatment For Functional Mitral Regurgitation

July 01, 2019

News Industry News

Neovasc Announces Treatment of 1,000th Refractory Angina Patient with Neovasc Reducer™

May 06, 2019

News Industry News

New Data Confirms Cardiac Dimensions' Carillon® System Provides Acute Hemodynamic Efficacy In Patients With Functional Mitral Regurgitation

April 26, 2019

News Industry News

Neovasc Announces Peer Reviewed Publication in the International Journal of Cardiology Demonstrating that the Neovasc Reducer™ Improves Diastolic Function in patients suffering from severe angina

April 17, 2019

News Industry News

FDA approves new indication for valve repair device to treat certain heart failure patients with mitral regurgitation

March 14, 2019

News Industry News

CardioMech Appoints Richard Nehm as President and CEO, and Mark Novotny as Chairman

November 06, 2018

News Industry News

Medtronic Announces Clinical Study of Transcatheter Aortic Valve Replacement in Aortic Stenosis Patients with Bicuspid Valves

September 18, 2018

News Industry News

Boston Scientific Announces Agreement to Acquire Claret Medical, Inc.

July 24, 2018

News Industry News

Edwards Granted CE Mark For First Transcatheter Tricuspid Therapy

May 01, 2018

News Industry News

HeartStitch® Inc. Announces CE Mark For CoAp Pro Mitral Valve Repair

April 19, 2018

Advertisement

Pi-Cardia Reports First Commercial Cases with ShortCut™

Pi-Cardia Receives FDA Market Clearance for ShortCut™

NuVera Medical Announces Positive Results From First-in-human Feasibility Study At 2020 TCT Conference

Cardiac Dimensions Announces Australian Therapeutic Goods Administration's Approval of the Carillon System for the Treatment of Functional Mitral Regurgitation

New Data Confirms Cardiac Dimensions’ Carillon® System Shows Favorable Long-Term Survival Rate In Patients With Functional Mitral Regurgitation

Abbott Announces European Approval Of Two Life-Saving Heart Devices For Babies And Children

Reduce Fmr Study Shows Cardiac Dimensions’ Carillon® System Significantly Improves Mitral Regurgitation And Slows Worsening Of Heart Failure

Abbott Launches World's First Pivotal Trial To Test New Approach For Repairing Leaky Tricuspid Heart Valves

Neovasc Provides Further Update on Reducer™ Program for Treatment of Refractory Angina

Abbott Receives U.S. Approval Of Next-Generation Mitraclip™, Bringing New Enhancements To Abbott's Leading Mitraclip Platform

Cardiac Dimensions Reaches 1,000 Implants Of Carillon® System, A Minimally Invasive Treatment For Functional Mitral Regurgitation

Neovasc Announces Treatment of 1,000th Refractory Angina Patient with Neovasc Reducer™

New Data Confirms Cardiac Dimensions' Carillon® System Provides Acute Hemodynamic Efficacy In Patients With Functional Mitral Regurgitation

Neovasc Announces Peer Reviewed Publication in the International Journal of Cardiology Demonstrating that the Neovasc Reducer™ Improves Diastolic Function in patients suffering from severe angina

FDA approves new indication for valve repair device to treat certain heart failure patients with mitral regurgitation

CardioMech Appoints Richard Nehm as President and CEO, and Mark Novotny as Chairman

Medtronic Announces Clinical Study of Transcatheter Aortic Valve Replacement in Aortic Stenosis Patients with Bicuspid Valves

Boston Scientific Announces Agreement to Acquire Claret Medical, Inc.

Edwards Granted CE Mark For First Transcatheter Tricuspid Therapy

HeartStitch® Inc. Announces CE Mark For CoAp Pro Mitral Valve Repair

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content